The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-((4-chloro-3-(trifluoromethyl)phenyl)sulfonamido)-4-phenylbutanoic acid ID: ALA5186294
PubChem CID: 168279231
Max Phase: Preclinical
Molecular Formula: C17H15ClF3NO4S
Molecular Weight: 421.82
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)[C@H](CCc1ccccc1)NS(=O)(=O)c1ccc(Cl)c(C(F)(F)F)c1
Standard InChI: InChI=1S/C17H15ClF3NO4S/c18-14-8-7-12(10-13(14)17(19,20)21)27(25,26)22-15(16(23)24)9-6-11-4-2-1-3-5-11/h1-5,7-8,10,15,22H,6,9H2,(H,23,24)/t15-/m0/s1
Standard InChI Key: MRCMNWQMINJPCR-HNNXBMFYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
-2.8573 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1427 1.4435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4308 1.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4308 0.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1408 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8573 0.2027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5720 -0.2096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5720 -1.0350 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.2867 0.2027 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.2867 -0.6223 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.7160 -0.2060 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.0014 0.2065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7131 -0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4278 0.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1295 -0.9221 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3043 -0.9221 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5720 1.4439 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.7131 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4278 -1.4439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0014 -1.4439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1425 -0.2060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8571 0.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8574 1.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5702 1.4423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2851 1.0297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2867 0.2086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5749 -0.2079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
7 8 1 0
7 9 1 0
7 10 1 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
11 15 2 0
11 16 2 0
1 17 1 0
13 18 1 1
18 19 2 0
18 20 1 0
14 21 1 0
21 22 1 0
23 22 2 0
24 23 1 0
25 24 2 0
26 25 1 0
27 26 2 0
22 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 421.82Molecular Weight (Monoisotopic): 421.0362AlogP: 3.72#Rotatable Bonds: 7Polar Surface Area: 83.47Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.35CX Basic pKa: ┄CX LogP: 4.43CX LogD: 1.01Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.71Np Likeness Score: -1.16
References 1. Tabuse H, Abe-Sato K, Kanazawa H, Yashiro M, Tamura Y, Kamitani M, Hitaka K, Gunji E, Mitani A, Kojima N, Oka Y.. (2022) Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1' Subsite Binder with Short Peptides., 65 (19.0): [PMID:36137271 ] [10.1021/acs.jmedchem.2c01088 ]